Treatments For Mild Cognitive Impairment Unlikely To Reduce Payer Costs – OptumInsight Exec
Executive Summary
Mild cognitive impairment has become an important focus in research on treating Alzheimer’s disease, based on the drive toward early intervention. But a lack of data on the condition complicates the development of economic models that could persuade payers about the cost effectiveness of treatments.